Unknown PHASE1 INTERVENTIONAL 3-arm NCT04235426

Platelet Rich Plasma Injection Versus Surgical and Medical Treatment of Mild-moderate Carpel Tunnel Syndrome.

Sponsor: Dalia Salah Saif

Interventions 30 patients received conventional medical treatment (NSAIDs, diclofenac 150 mg/day for 2 weeks and 1500 g vitamin B 12 per day for 6 weeks) and hand support. 30 patients went to surgical procedure Injection

Updated 5 times since 2020 Last updated: Jan 18, 2020 Started: Jan 26, 2018 Primary completion: Jan 31, 2021 Completion: Jan 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04235426, this PHASE1 trial focuses on Carpal Tunnel and remains ongoing. Sponsored by Dalia Salah Saif, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Active Not Recruiting PHASE1
Feb 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE1

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dalia Salah Saif

Data source: Menoufia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt